Stockreport

U.S. Food and Drug Administration (FDA) Accepts for Priority Review Bristol Myers Squibb’s Application for CC-486 for Maintenance Treatment of Adult Patients in Remission with Acute Myeloi...

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF U.S. FDA set target action date of September 3, 2020Application based on results from the Phase 3 QUAZAR®-AML-001 study PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Mye [Read more]